Finally, treatment of mice possessing actively growing orthotopic glioma xenografts with the GLO1 inhibitor S-(p-bromobenzyl) glutathione dicyclopentyl ester (p-BrBzGSH(Cp)2) resulted in significantly reduced tumor growth with limited off-target effects in normal brain. The gene discussed is GLO1; the disease is central nervous system cancer.